Fidelity Advisor Biotechnology Fund: Class I
Fidelity Advisor Biotechnology Fund: Class I (FBTIX)
"This fund primarily invests in common stocks. Typically, at least 80% of its assets are dedicated to companies actively involved in the discovery, advancement, production, and sale of biotechnology-related offerings (products, services, and processes), as well as companies positioned to significantly gain from scientific and technological breakthroughs in biotechnology. The fund's holdings include both U.S. and foreign companies. Investment decisions are guided by comprehensive fundamental analysis, evaluating factors like each issuer's financial stability, competitive position, and broader market and economic conditions. It is structured as a non-diversified fund."
FBTIX Mutual Fund Chart & Stats
- Previous Close
- $53.28
- Sub-Category
- Sector-Specific
- Total Liabilities
- $56.19M
- Last Dividend Ex-Date
- Dec 26, 2025
- Expense Ratio
- 0.69%
- Holding Count
- 78
- Brand
- Fidelity Advisor Series Vii
- Dividend Yield
- (1.07%)
- Category
- Equity
- Total Assets
- 2.26B
- Shares Outstanding
- N/A
- 52-Week Range
- $39.74 - $57.68
FBTIX Mutual Fund News
FBTIX Mutual Fund Smart Score
Top 10 Holdings
| Name | Weight % |
|---|---|
| ABBVAbbvie | 14.71% |
| GILDGilead Sciences | 5.70% |
| SYRESpyre Therapeutics, Inc | 3.83% |
| ALNYAlnylam Pharmaceuticals | 3.62% |
| DNTHDianthus Therapeutics, Inc. | 3.55% |
| COGTCogent Biosciences, Inc. | 3.25% |
| ORKAOruka Therapeutics, Inc. | 3.24% |
| INSMInsmed | 3.05% |
| RVMDRevolution Medicines, Inc. | 3.00% |
| ARGXArgenx | 3.00% |
| Total | 46.95% |
Recently Viewed
No data currently available






